Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08907_nanopub.RAeL4tcWpnrqbu7u8kV3TI9GGAl2OymhfRMHl0TLaidHw#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB08907 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08907 label "Canagliflozin [drugbank:DB08907]" assertion.
- drugbank:DB08907 seeAlso DB08907 assertion.
- drugbank:DB08907 seeAlso invokana.html assertion.
- drugbank:DB08907 seeAlso invokana-drug.htm assertion.
- drugbank:DB08907 identifier "drugbank:DB08907" assertion.
- drugbank:DB08907 description "Canagliflozin belongs to a new class of anti-diabetic drugs that works by inhibiting the sodium-glucose transport protein (SGLT2). This transport protein is found in the kidney and is responsible for reabsorbing glucose that has been filtered. FDA approved on March 29, 2013." assertion.
- drugbank:DB08907 title "Canagliflozin" assertion.
- drugbank:DB08907 bio2rdf_vocabulary:identifier "DB08907" assertion.
- drugbank:DB08907 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08907 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08907" assertion.
- drugbank:DB08907 bio2rdf_vocabulary:x-identifiers.org DB08907 assertion.
- drugbank:DB08907 drugbank_vocabulary:drugbank-id "DB08907" assertion.
- drugbank:DB08907 drugbank_vocabulary:x-cas cas:842133-18-0 assertion.
- drugbank:DB08907 drugbank_vocabulary:x-ahfs ahfs:68:20.18 assertion.
- drugbank:DB08907 drugbank_vocabulary:x-chebi chebi:73274 assertion.
- drugbank:DB08907 drugbank_vocabulary:x-kegg kegg:D09592 assertion.
- drugbank:DB08907 drugbank_vocabulary:x-wikipedia wikipedia:Canagliflozin assertion.
- drugbank:DB08907 drugbank_vocabulary:x-ndc ndc:50458-141-30 assertion.